-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

616.O1.6 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Novel Uses of Approved Therapeutic Agents

Symposia: Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, APL, Clinical Research, Diseases, Myeloid Malignancies
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Room 6A (San Diego Convention Center)
Moderators:
Jacob S. Appelbaum, MD, PhD, Fhcrc/Seattle Cancer Care Alliance and Catherine Lai, MD, University of Pennsylvania
Disclosures:
Lai: AbbVie: Consultancy; Astellas: Consultancy; Rigel: Consultancy; BMS: Consultancy; Genentech: Consultancy; Novartis: Consultancy; Daiichi: Consultancy; Taiho: Consultancy; Pfizer: Consultancy; Jazz: Consultancy, Research Funding.
This session includes combinations of drugs that are currently FDA approved and are being used in dosing and combinations that have not been tried before with good outcomes.
2:00 PM

Harinder Gill, MD, MBBS, FRCP, FRCPath1, Rita Yim1*, Lynn Chin1*, Paul Lee1*, Vivian Li1*, Lester Au1*, Garret Man Kit Leung1*, Ka Leung Daniel Cheuk, MBBS2*, Shau-Yin Ha, MBBS3*, Chi Kong Li4, Melissa Ooi, PhD, FRCPath, MBBChir, MRCP5*, Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP6, Patrick Chu, MD7*, Cyrus Kumana1* and Yok Lam Kwong, MD1*

1Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
2Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong
3Department of Paediatric and Adolescent Medicine, The University of Hong Kong, Hong Kong, Hong Kong
4Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong
5National University Cancer Institute, Singapore, Singapore
6Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
7Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China

2:15 PM

Musa Yilmaz, MD1*, Muharrem Muftuoglu, MD2, Courtney D. DiNardo, MD, MSc1, Tapan M. Kadia, MD1, Marina Y. Konopleva, MD, PhD1,3*, Gautam Borthakur, MD1, Naveen Pemmaraju, MD1, Nicholas J. Short, MD1, Yesid Alvarado Valero, MD1, Abhishek Maiti, MD1, Lucia Masarova, MD1, Guillermo Montalban-Bravo, MD1, Carissa Jurisprudencia4*, Allison Pike, RN1*, Sanam Loghavi, MD5, Keyur P. Patel, MBBS, PhD6, Guilin Tang, MD, PhD7*, Jairo Matthews, BA8*, Steven M. Kornblau, MD1, Elias Jabbour9, Guillermo Garcia-Manero, MD10, Farhad Ravandi, MD, MBBS1, Michael Andreeff, MD PhD1 and Naval Daver, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Cancer Center, Albert Einstein College of Medicine, New York, NY
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Hematopathology, MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
8The University of Texas at MD Anderson Cancer center, Houston, TX
9University of Texas M.D. Anderson Cancer Ctr., Houston, TX
10University of Texas MD Anderson Cancer Center, Houston, TX

2:30 PM

Guillaume Richard-Carpentier, MD, FRCPC1, Gopila Gupta1*, Charina Cameron, BSc, RN1*, Severine Cathelin, PhD1*, Aniket Bankar, MD, MBBS, MSc, DM1, Marta Beata Davidson, MD, PhD1, Vikas Gupta, MD1, Dawn C. Maze, MD, FRCPC, MSc1, Mark D. Minden1*, Tracy Murphy, MD, FRCP, FRCPath1*, Aaron D. Schimmer, MD1, Andre C. Schuh, MD, FRCPC2, Hassan Sibai, MD1, Karen Yee, MD, FRCPC1*, Courtney D. DiNardo, MD, MSc3, Joseph Brandwein, MD4, Caroline Jane McNamara, MBBS5* and Steven M. Chan, MD, PhD6

1Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
2Department of Medical Oncology and Hematology, University Health Network- University of toronto, Toronto, ON, Canada
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of Alberta Hospital, Edmonton, AB, Canada
5Haematology and Bone Marrow Transplant, Royal Brisbane and Women's Hospital, Herston, QLD, Australia
6Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

2:45 PM

Leo Ruhnke, MD1*, Christoph Schliemann, MD2*, Jan-Henrik Mikesch, MD2*, Matthias Stelljes, MD3, Lars Fransecky4*, Björn Steffen, MD5*, Martin Kaufmann, MD6, Andreas Burchert, MD7, Andreas Rank, MD8*, Maher Hanoun, MD, PhD9*, Alexander Höllein, MD10*, Sabrina Kraus, MD11*, Mathias Hänel, MD12, Kerstin Schäfer-Eckart, MD13*, Annett Haake1*, Frank Fiebig1*, Sven Zukunft1*, Jan Moritz Middeke, MD14*, Désirée Kunadt, MD1*, Johannes Schetelig, MD, MSc15, Malte von Bonin, MD1*, Maximilian Alexander Röhnert, MD1*, Uta Oelschlägel, PhD1*, Friedrich Stölzel, MD16*, Claudia D Baldus, MD4*, Hubert Serve, MD5, Martin Wermke, MD1*, Martin Bornhäuser, MD17* and Christoph Röllig, MD, MSc1*

1Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
2Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
3Department of Internal Medicine A, University of Muenster, Muenster, Germany
4Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
5Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
6Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany
7Department of Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
8Department of Internal Medicine II, University Hospital Augsburg, Augsburg, Germany
9Department of Hematology, University Hospital Essen, Essen, Germany
10Department of Internal Medicine III, Rotkreuz Hospital Munich, Munich, Germany
11Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
12Department of Internal Medicine III, Hematology, Oncology and Cellular Therapies, Hospital Chemnitz, Chemnitz, Germany
13Department of Internal Medicine V, Paracelsus University Hospital Nuremberg, Nuremberg, Germany
14Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
15TU Dresden, Dresden, Saxony, Germany
16Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
17Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

3:00 PM

Sylvain Garciaz1*, Sarah Bertoli2*, David A Sallman, MD3, Justine Decroocq, MD4*, Pierre-Yves Dumas, MD, PhD5*, Amine Belhabri, MD6*, Corentin Orvain7*, Gaspar Aspas Requena, MD8*, Celestine Simand, MD9*, Kamel Laribi10*, Martin Carré, MD11*, Alberto Santagostino12*, Ludovic Gabellier, MD, PhD13*, Marie Anne Hospital14*, Ariane Mineur15*, Arnaud Pigneux, MD, PhD16*, Norbert Vey, MD17 and Christian Récher, MD18*

1Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France
2IUCT-Oncopole, Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
3H. Lee Moffitt Cancer Center, Tampa, FL
4Clinical Hematology Department, Hopital Cochin, APHP, Paris, France, Paris, France
5Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
6Centre Leon Berard, Lyon, FRA
7Hematology Department, Angers University Hospital, Angers, France
8Hématologie, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France
9Hematology, Institut de Cancerologie Strasbourg Europe (ICANS), Strasbourg, France
10Hematology Department, Le Mans Hospital, Le Mans, France
11Hematology Department, CHU Grenoble, Grenoble, France
12CH Troyes, Troyes, FRA
13Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
14Hematology Department, Institut Paoli-Calmettes, Marseille, France
15Hôpital Haut-Lévèque, FILO Group Coordination, Pessac, France
16Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
17Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France
18IUCT-Oncopole, Hematology Department, CHU Toulouse, Toulouse, France

3:15 PM

Naval Daver, MD1, Kyoo Hyung Lee, MD, PhD2*, Yunsuk Choi, MD, PhD3, Brian A. Jonas, MD, PhD4, Martha Arellano5, Paul B. Koller, MD6, Chul W. Jung, MD7, Sang Kyun Sohn8*, Amir T. Fathi, MD9, Jeong-Ok Lee, MD10, Sung-Soo Yoon, MD, PhD11, Justin M. Watts, MD12, Pankit Vachhani, MD13*, Ho-Jin Shin, MD14*, Jia Hu, PhD15*, Ranjeet Sinha, PhD15*, Nawazish Khan, MD, MS15*, William G. Rice, PhD15 and Rafael Bejar, MD, PhD15

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Asan Medical Center, Seoul, Korea, Republic of (South)
3Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
4Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
5Emory University School of Medicine, Atlanta, GA
6Hematology/HCT, City of Hope National Medical Center, Duarte, CA
7Samsung Medical Center, Seoul, KOR
8Kyungpook National University Chilgok Hospital, Daegu, Korea, Republic of (South)
9Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
10Department of Internal Medicine, Seoul National Univ. Bundang Hospital, Seongnam-Si, None, KOR
11Seoul National University Hospital, Seoul, South Korea
12Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, MIAMI, FL
13O'Neal Comprehensive Cancer Center at the UAB, Birmingham, AL
14Pusan National University Hospital, Busan, Korea, Republic of (South)
15Aptose Biosciences, San Diego, CA

*signifies non-member of ASH